IMS Gear to invest 6 mln euro in new plant in Croatia's Osijek - mayor
Most Bulgarian stock indices rise, AmonRa Energy shines
Albania's gross foreign debt rises 2.4% y/y in Q3
Bulgaria's Puldin Holding acquires TIZ Invest
Albania sells 29.5 mln euro of 2028 T-notes
Nov 19, 2009 16:44 EEST
BUCHAREST (Romania), November 19 (SeeNews) – Romania's competition regulator said on Thursday it has launched an investigation into suspected unfair competition resulting from the acquisition by U.S. private equity fund Advent of some of the local assets of British pharmaceuticals company Ozone Laboratories.
Romanian companies Ozone Laboratories Pharma and Perpetuem Limited, both owned by Advent, had notified the Competition Council they were taking control of some assets of Ozone Laboratories in Romania, but the deal was wrapped up without the council’s approval, the regulator said in a statement.
You can subscribe to our M&A newsletter here
Advent also holds majority stakes in Romanian paints maker Dufa Deutek and tile maker Ceramica.
You have run out of free articles this month.
Sign up in for
and get ten (10) free articles per month or sign up for
and get unlimited access.
Browse our free newsletter options